ConductScience.org, home

Paper31375673

Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML.

Oellerich T and 23 others. Nat Commun, 2019. Cited by 54 papers, by iCite.

Cite this record

ConductScience Library. Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML. Papers, record 31375673. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31375673

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML.
PubMed
Journal
Nat Commun
PubMed
Year
2019
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
54
iCite
Relative citation ratio, by iCite
1.84
iCite
Revised in PubMed
2021-01-10
PubMed

Authors24

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Oellerich TThomas
2Schneider CConstanze
3Thomas DDominique
4Knecht KMKirsten Mhttps://orcid.org/0000-0001-5892-3770
5Buzovetsky OOlga
6Kaderali LLars
7Schliemann CChristoph
8Bohnenberger HHanibalhttps://orcid.org/0000-0003-1038-1030
9Angenendt LLinushttps://orcid.org/0000-0003-2502-9910
10Hartmann WWolfganghttps://orcid.org/0000-0002-7609-5021
11Wardelmann EEvahttps://orcid.org/0000-0001-6788-4910
12Rothenburger TTamara
13Mohr SSebastian
14Scheich SSebastianhttps://orcid.org/0000-0001-6408-3536
15Comoglio FFedericohttps://orcid.org/0000-0002-8970-6610
16Wilke AAnne
17Ströbel PPhilipp
18Serve HHuberthttps://orcid.org/0000-0001-8472-5516
19Michaelis MMartinhttps://orcid.org/0000-0002-5710-5888
20Ferreirós NNerea

Source PubMed

See all 24 authorsDownload CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antimetabolites, AntineoplasticMajor topic
Biomarkers, TumorMajor topic
Drug Resistance, NeoplasmMajor topic
Leukemia, Myeloid, AcuteMajor topic
SAM Domain and HD Domain-Containing Protein 1Major topic
Animals
Azacitidine
Bone Marrow
Cell Line, Tumor
DNA Methylation
Decitabine
Female
Gene Expression Regulation, Leukemic
Humans
Mice
Patient Selection
Primary Cell Culture
Retrospective Studies
Treatment Outcome
Xenograft Model Antitumor Assays

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R21 AI136737NIAID NIH HHSUnited StatesR21AI136737PubMedNIH RePORTER
T32 GM008283NIGMS NIH HHSUnited StatesT32GM008283PubMedNIH RePORTER

Download CSV of grants

References64

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128693797Azacitidine in adult patients with acute myeloid leukemia.Crit Rev Oncol Hematol2017https://conductscience.org/library/papers/28693797PubMed
225644037Identification of flubendazole as potential anti-neuroblastoma compound in a large cell line screen.Sci Rep2015https://conductscience.org/library/papers/25644037PubMed
325755265A High-Throughput Enzyme-Coupled Assay for SAMHD1 dNTPase.J Biomol Screen2015https://conductscience.org/library/papers/25755265PubMed
429339097Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study.Lancet Oncol2018https://conductscience.org/library/papers/29339097PubMed
527330573A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancers.Clin Epigenetics2016https://conductscience.org/library/papers/27330573PubMed
625716206Decitabine priming enhances the antileukemic effects of exportin 1 (XPO1) selective inhibitor selinexor in acute myeloid leukemia.Blood2015https://conductscience.org/library/papers/25716206PubMed
730084010Predictors of clinical responses to hypomethylating agents in acute myeloid leukemia or myelodysplastic syndromes.Ann Hematol2018https://conductscience.org/library/papers/30084010PubMed
829543073Epigenetic therapy: azacytidine and decitabine in acute myeloid leukemia.Expert Rev Hematol2018https://conductscience.org/library/papers/29543073PubMed
919230772Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.Lancet Oncol2009https://conductscience.org/library/papers/19230772PubMed
101710634A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry.J Immunol Methods1991https://conductscience.org/library/papers/1710634PubMed
1120702620Endogenous CD317/Tetherin limits replication of HIV-1 and murine leukemia virus in rodent cells and is resistant to antagonists from primate viruses.J Virol2010https://conductscience.org/library/papers/20702620PubMed
1211483751Susceptibility of rat-derived cells to replication by human immunodeficiency virus type 1.J Virol2001https://conductscience.org/library/papers/11483751PubMed
1325015816Cell cycle control and HIV-1 susceptibility are linked by CDK6-dependent CDK2 phosphorylation of SAMHD1 in myeloid and lymphoid cells.J Immunol2014https://conductscience.org/library/papers/25015816PubMed
1429708172Current PD-L1 immunohistochemistry for non-small cell lung cancer.J Thorac Dis2018https://conductscience.org/library/papers/29708172PubMed
1525267621Structural basis of cellular dNTP regulation by SAMHD1.Proc Natl Acad Sci U S A2014https://conductscience.org/library/papers/25267621PubMed
1622439938Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells.Cancer Cell2012https://conductscience.org/library/papers/22439938PubMed
1725532805Cyclin L2 is a critical HIV dependency factor in macrophages that controls SAMHD1 abundance.Cell Host Microbe2015https://conductscience.org/library/papers/25532805PubMed
1815572771REFMAC5 dictionary: organization of prior chemical knowledge and guidelines for its use.Acta Crystallogr D Biol Crystallogr2004https://conductscience.org/library/papers/15572771PubMed
1928209616OCTN1 Is a High-Affinity Carrier of Nucleoside Analogues.Cancer Res2017https://conductscience.org/library/papers/28209616PubMed
2029670289SAMHD1 acts at stalled replication forks to prevent interferon induction.Nature2018https://conductscience.org/library/papers/29670289PubMed

See all 64 referencesDownload CSV of references

Cited by46

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.

PMIDTitleJournalYearIn PapersSource
42925407Decitabine and azacitidine exert multifaceted effects beyond DNA hypomethylation in myeloid neoplasms.Int J Hematol2026https://conductscience.org/library/papers/42925407PubMed
42592050Nucleotide Metabolism in Health and Disease.MedComm (2020)2026https://conductscience.org/library/papers/42592050PubMed
42340493Predicting response to hypomethylating agents in myeloid neoplasms: a robust model.Ann Hematol2026https://conductscience.org/library/papers/42340493PubMed
41888396Synergizing hypomethylating agents with off-the-shelf CD70-targeted chimeric antigen receptor-engineered natural killer T cells for the treatment of acute myeloid leukemia.Leukemia2026https://conductscience.org/library/papers/41888396PubMed
41748545RRM1 inhibition sensitizes lung adenocarcinoma to decitabine treatment.Cell Death Dis2026https://conductscience.org/library/papers/41748545PubMed
41617034Allosteric targeting with antiviral nucleotide analogs allows fine-tuning of SAMHD1 dNTPase activity.J Biol Chem2026https://conductscience.org/library/papers/41617034PubMed
41577852Efficacy of azacitidine in meningiomas and explorative analyses of underlying molecular mechanisms.Neurosurg Rev2026https://conductscience.org/library/papers/41577852PubMed
41503213Prognostic value of BTG1 for predicting decitabine sensitivity in de novo acute myeloid leukemia.iScience2026https://conductscience.org/library/papers/41503213PubMed
41392286Selective depletion of tumor-associated SAMHD1 enhances chemotherapeutic efficacy and antitumor immune responses.Signal Transduct Target Ther2025https://conductscience.org/library/papers/41392286PubMed
41370931Targeting Genome Maintenance Defects of Cancers Using Chain-Terminating Nucleoside Analogs.Cancer Sci2026https://conductscience.org/library/papers/41370931PubMed
41057684Genetic and epigenetic alterations at secondary resistance after continued decitabine-based treatment of acute myeloid leukemia in the randomized phase II DECIDER trial.Leukemia2025https://conductscience.org/library/papers/41057684PubMed
40902696Continuous assay for the dNTP triphosphohydrolase of activated SAMHD1.Anal Biochem2026https://conductscience.org/library/papers/40902696PubMed
40533858Advances and challenges in the treatment of myelodysplastic syndromes.Exp Hematol Oncol2025https://conductscience.org/library/papers/40533858PubMed
40507894Acquired Resistance to Decitabine Associated with the Deoxycytidine Kinase A180P Mutation: Implications for the Order of Hypomethylating Agents in Myeloid Malignancies Treatment.Int J Mol Sci2025https://conductscience.org/library/papers/40507894PubMed
40362245From Chemotherapy to Targeted Therapy: Unraveling Resistance in Acute Myeloid Leukemia Through Genetic and Non-Genetic Insights.Int J Mol Sci2025https://conductscience.org/library/papers/40362245PubMed
39003408Novel Vpx virus-like particles to improve cytarabine treatment response against acute myeloid leukemia.Clin Exp Med2024https://conductscience.org/library/papers/39003408PubMed
38906675The type of DNA damage response after decitabine treatment depends on the level of DNMT activity.Life Sci Alliance2024https://conductscience.org/library/papers/38906675PubMed
38760575Decitabine cytotoxicity is promoted by dCMP deaminase DCTD and mitigated by SUMO-dependent E3 ligase TOPORS.EMBO J2024https://conductscience.org/library/papers/38760575PubMed
38710701Platform-directed allostery and quaternary structure dynamics of SAMHD1 catalysis.Nat Commun2024https://conductscience.org/library/papers/38710701PubMed
38406263SAMHD1 expression contributes to doxorubicin resistance and predicts survival outcomes in diffuse large B-cell lymphoma patients.NAR Cancer2024https://conductscience.org/library/papers/38406263PubMed

See all 46 cited byDownload CSV of cited by

Genes37

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ASXL1171023PubTator's text mininghttps://conductscience.org/library/genes/171023NCBI Gene
BCAR19564PubTator's text mininghttps://conductscience.org/library/genes/9564NCBI Gene
CAT847PubTator's text mininghttps://conductscience.org/library/genes/847NCBI Gene
CD19930PubTator's text mininghttps://conductscience.org/library/genes/930NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD33945PubTator's text mininghttps://conductscience.org/library/genes/945NCBI Gene
CD34947PubTator's text mininghttps://conductscience.org/library/genes/947NCBI Gene
CDA978PubTator's text mininghttps://conductscience.org/library/genes/978NCBI Gene
CHEK211200PubTator's text mininghttps://conductscience.org/library/genes/11200NCBI Gene
CUL4A8451PubTator's text mininghttps://conductscience.org/library/genes/8451NCBI Gene
DCK1633PubTator's text mininghttps://conductscience.org/library/genes/1633NCBI Gene
DCTD1635PubTator's text mininghttps://conductscience.org/library/genes/1635NCBI Gene
DNMT11786PubTator's text mininghttps://conductscience.org/library/genes/1786NCBI Gene
DNMT3A1788PubTator's text mininghttps://conductscience.org/library/genes/1788NCBI Gene
GAPDH2597PubTator's text mininghttps://conductscience.org/library/genes/2597NCBI Gene
GYPA2993PubTator's text mininghttps://conductscience.org/library/genes/2993NCBI Gene
H2AX3014PubTator's text mininghttps://conductscience.org/library/genes/3014NCBI Gene
MRE114361PubTator's text mininghttps://conductscience.org/library/genes/4361NCBI Gene
MT-RNR14549PubTator's text mininghttps://conductscience.org/library/genes/4549NCBI Gene
PARP1142PubTator's text mininghttps://conductscience.org/library/genes/142NCBI Gene

See all 37 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31375673

GET https://conductscience.org/api/papers/v1/31375673/authors?page=2